investordatabase.org

Rhenman & Partners Asset Management AB

rhepa.se Direct investor

Rhenman & Partners Asset Management is a Swedish asset manager that acts as portfolio manager of healthcare-focused long/short hedge funds. It invests exclusively in the healthcare sector, with portfolio managers specialised by sub-sector.

Rhenman & Partners Asset Management AB is an asset manager headquartered in Stockholm, Sweden. It invests directly in companies, in healthcare, pharmaceuticals, biotechnology and medical technology.

“På Rhenman & Partners investerar vi endast i hälsovårdssektorn och vår investeringsprocess tar hänsyn till både vetenskapliga och finansiella överväganden.”

— Rhenman & Partners Asset Management AB, own website
Layer
Direct investor
Type
Asset manager
Stage
Not stated
Headquarters
Stockholm, Sweden
Sectors
healthcare, pharmaceuticals, biotechnology, medical technology, healthcare services

Team, as Rhenman & Partners Asset Management AB publishes it

  • Henrik Rhenman Grundare / Chief Investment Officer
  • Kaspar Hållsten Chief Investment Officer (Rhenman Healthcare Next Generation L/S) / Portföljförvaltare – Medicinsk teknik
  • Amennai Beyeen, PhD Portföljförvaltare – Biopharma
  • Camilla Oxhamre Cruse, PhD, MBA Portföljförvaltare – Biopharma
  • Hugo Schmidt Portföljförvaltare – Hälsovårdstjänster

Names and roles exactly as listed on rhepa.se. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Rhenman & Partners Asset Management AB publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 15842 · added 2026-10-21 · link last verified 2026-10-21 · confidence medium

Similar investors

Listed under